Dynamic enhancing vascular pattern of intrahepatic peripheral cholangiocarcinoma on contrast-enhanced ultrasound: The influence of chronic hepatitis and cirrhosis

Abdominal Imaging

Volumn 38, Issue 1, 2013, Pages 112-119

  Li, Rui ^a   Zhang, Xiaohang ^a   Ma, Kuan Sheng ^a   Li, Xiao Wu ^a   Xia, Feng ^a   Zhong, Hua ^a   Tang, Chun Lin ^a   Guo, Yanli ^a   Yan, Xiao Chu ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Chronic hepatitis; Cirrhosis; Contrast agent; Intrahepatic peripheral cholangiocarcinoma; Ultrasound

Indexed keywords

SONOVUE;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT DILATATION; CANCER PATIENT; CHILD PUGH SCORE; CLINICAL FEATURE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; HEPATITIS B; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; INTRAHEPATIC PERIPHERAL CHOLANGIOCARCINOMA; LIVER CIRRHOSIS; LIVER NODULE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHI-SQUARE DISTRIBUTION; CHOLANGIOCARCINOMA; CONTRAST MEDIA; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; SULFUR HEXAFLUORIDE;

EID: 84872678059     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-012-9854-x     Document Type: Article

References (24)

1. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005) Cholangiocarcinoma. Lancet 366:1303-1314 (Pubitemid 41416587)
2. Shaib Y, El-Serag H (2004) The epidemiology of cholangiocarcinoma. Semin Liver Dis 24:115-125 (Pubitemid 38738341)
3. Davila JA, El-Serag HB (2002) Cholangiocarcinoma: the "other" liver cancer on the rise. Am J Gastroenterol 97:3199-3200 (Pubitemid 35424597)
4. Blechacz B, Gores GJ (2008) Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48:308-321 (Pubitemid 351975555)
5. Shaib YH, El-Serag HB, Nooka AK, et al. (2007) Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a hospital-based case-control study. Am J Gastroenterol 102:1016-1021
6. Khan SA, Davidson BR, Goldin R, et al. (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51(Suppl 6):vi1-vi9
7. Chen LD, Xu HX, Xie XY, et al. (2008) Enhancement patterns of intrahepatic cholangiocarcinoma: comparison between contrast-enhanced ultrasound and contrast-enhanced CT. Br J Radiol 81:881-889
8. D'Onofrio M, Vecchiato F, Cantisani V, et al. (2008) Intrahepatic peripheral cholangiocarcinoma (IPCC): comparison between perfusion ultrasound and CT imaging. Radiol Med 113:76-86 (Pubitemid 351387208)
9. Li R, Guo Y, Hua X, et al. (2007) Characterization of focal liver lesions: comparison of pulse-inversion harmonic contrast-enhanced sonography with contrast-enhanced CT. J Clin Ultrasound 35:109-117 (Pubitemid 46697187)
10. Celli N, Gaiani S, Piscaglia F, et al. (2007) Characterization of focal liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol 19:3-14 (Pubitemid 46066862)
11. Xu HX, Liu GJ, Lu MD, et al. (2006) Characterization of focal liver lesions using contrast-enhanced sonography with a low mechanical index mode and a sulfur hexafluoride-filled microbubble contrast agent. J Clin Ultrasound 34:261-272 (Pubitemid 44015493)
12. Xu HX, Lu MD, Liu GJ, et al. (2006) Imaging of peripheral cholangiocarcinoma with low-mechanical index contrast-enhanced sonography and SonoVue: initial experience. J Ultrasound Med 25:23-33
13. Vilana R, Forner A, Bianchi L, et al. (2010) Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrast-enhanced ultrasound. Hepatology 51:2020-2029
14. Wilson SR, Kim TK, Jang H-J, Burns PN (2007) Enhancement patterns of focal liver masses: discordance between contrast-enhanced sonography and contrast-enhanced CT and MRI. AJR Am J Roentgenol 189:W7-W12 (Pubitemid 46983197)
15. Bolondi L, Gaiani S, Celli N, et al. (2005) Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. Hepatology 42:27-34 (Pubitemid 40911308)
16. Lok ASF, Mcmahon BJ (2007) AASLD practice guideline chronic hepatitis B. Hepatology 45:507-539 (Pubitemid 46374607)
17. Poultsides GA, Zhu AX, Choti MA, Pawlik TM (2010) Intrahepatic cholangiocarcinoma. Surg Clin N Am 90:817-837
18. Bruix J, Sherman M (2005) Management of hepatocellular carcinoma. AASLD practice guideline. Hepatology 42:1208-1236 (Pubitemid 43112690)
19. Quaia E, Calliada F, Bertolotto M, et al. (2004) Characterization of focal liver lesions with contrast specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence. Radiology 232:420 (Pubitemid 38971282)
20. Catala V, Nicolau C, Vilana R, et al. (2007) Characterization of focal liver lesions: comparative study of contrast-enhanced ultrasound versus spiral computed tomography. Eur Radiol 17:1066-1073 (Pubitemid 46766888)
21. Celli N, Gaiani S, Piscaglia F, et al. (2007) Characterization of focal liver lesions by real-time contrast-enhanced ultrasonography. Eur J Gastroenterol Hepatol 19:3-14 (Pubitemid 46066862)
22. Claudon M, Cosgrove D, Albrecht T et al. (2008) Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) - update 2008. Ultrschall in Med 29:28-44 (Pubitemid 351294171)
23. Beaton C, Cochlin D, Kumar N (2010) Contrast-enhanced ultrasound should be the initial radiological investigation to characterize focal liver lesions. Eur J Surg Oncol 36:43-46
24. Lencioni R, Piscalia F, Bolondi L (2008) Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma. J Hepatol 48:848-857